Furthermore, it is well known that highly fibrotic tumors limit T lymphocyte entry into the tumor microenvironment (T cell excluded tumors) and thus are resistant to anti-PD-1/PD-L1 antibody therapy. Here, CD274 is linked to neoplasm.